Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KineMed, Inc.
Emeryville, California, United Stateskinemed.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
KineMed developed proprietary translational medicine technologies enabling real-time measurement of biochemical pathway activity in both preclinical models and humans. The company partnered with major pharma companies to develop kinetic biomarkers but does not appear to have advanced its own drugs into late-stage clinical trials before becoming inactive.
- Therapeutic areas
- CardiovascularMetabolic DisordersImmunologyOncologyNeurology
- Modalities
- Small molecules (inferred from drug discovery and development focus)Biomarker diagnosticsIsotope-labeled pharmacological measurements
- Industry
- Drug Discovery Services
02
Partnerships
GlaxoSmithKline (GSK) – multi-year agreement for kinetic biomarker developmentOrganon – collaboration for new therapeutic applications via pathway analysis
Beyond the preview
Go deeper on KineMed, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KineMed, Inc..